Chemometec A/S CHEMM.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

725.50

+2.76%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in DKK, from our data supplier.

FY2026

Revenue

DKK 511.1m

FY2017FY2026

Net income

DKK 201.8m

FY2017FY2026

Free cash flow

DKK 182.0m

FY2017FY2026

Shareholders' equity

DKK 725.4m

FY2017FY2026

Income statement

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	DKK 511.1m	DKK 495.6m	DKK 407.9m	DKK 444.4m	DKK 428.4m	DKK 281.1m	DKK 214.1m	DKK 175.5m	DKK 112.7m	DKK 90.3m
Gross profit	DKK 486.0m	DKK 465.5m	DKK 367.6m	DKK 395.4m	DKK 384.3m	DKK 253.3m	DKK 193.9m	DKK 158.6m	DKK 99.5m	DKK 80.2m
Research and development	DKK 15.4m	DKK 10.4m	DKK 8.4m	DKK 7.2m	DKK 7.2m	DKK 6.5m	DKK 6.5m	DKK 5.7m	DKK 3.7m	DKK 3.8m
Operating income	DKK 251.0m	DKK 247.7m	DKK 178.8m	DKK 228.5m	DKK 204.7m	DKK 116.0m	DKK 77.5m	DKK 54.1m	DKK 24.3m	DKK 11.5m
Net income	DKK 201.8m	DKK 186.4m	DKK 136.3m	DKK 178.7m	DKK 159.5m	DKK 88.4m	DKK 59.2m	DKK 41.8m	DKK 18.2m	DKK 7.5m
Diluted earnings per share	11.60	10.71	7.83	10.26	9.16	5.08	3.40	2.56	1.19	0.48

Balance sheet

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Total assets	DKK 860.9m	DKK 828.0m	DKK 676.7m	DKK 658.0m	DKK 501.3m	DKK 344.9m	DKK 263.1m	DKK 238.2m	DKK 114.0m	DKK 97.6m
Cash and short-term investments	DKK 293.6m	DKK 341.8m	DKK 296.1m	DKK 316.6m	DKK 209.0m	DKK 150.1m	DKK 96.9m	DKK 98.2m	DKK 9.8m	DKK 12.4m
Total liabilities	DKK 135.5m	DKK 154.7m	DKK 111.4m	DKK 124.9m	DKK 144.1m	DKK 79.9m	DKK 60.4m	DKK 64.9m	DKK 41.0m	DKK 33.2m
Debt	DKK 4.6m	DKK 6.4m	DKK 4.2m	DKK 7.2m	DKK 6.8m	DKK 2.4m	DKK 2.3m	DKK 18.8m	DKK 20.1m	DKK 22.1m
Shareholders' equity	DKK 725.4m	DKK 673.4m	DKK 565.3m	DKK 533.0m	DKK 357.2m	DKK 265.0m	DKK 202.8m	DKK 173.3m	DKK 73.0m	DKK 64.4m
Shares outstanding	17m	17m	17m	17m	17m	17m	17m	16m	15m	16m

Cash flow

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash from operations	DKK 210.4m	DKK 207.4m	DKK 129.0m	DKK 154.1m	DKK 176.9m	DKK 107.9m	DKK 72.0m	DKK 58.3m	DKK 25.4m	DKK 9.8m
Capital spending	−DKK 28.3m	−DKK 29.9m	−DKK 43.5m	−DKK 40.8m	−DKK 55.9m	−DKK 24.6m	−DKK 26.7m	−DKK 27.1m	−DKK 16.5m	−DKK 10.6m
Free cash flow	DKK 182.0m	DKK 177.6m	DKK 85.5m	DKK 113.3m	DKK 120.9m	DKK 83.3m	DKK 45.3m	DKK 31.2m	DKK 9.0m	−DKK 833,000
Dividends paid	−DKK 123.3m	−DKK 69.6m	−DKK 104.4m	—	−DKK 69.6m	−DKK 26.1m	−DKK 348.1m	−DKK 136.0m	−DKK 136.0m	−DKK 136.0m

Latest quarters

By quarter end

	Jun 2026	Dec 2025	Jun 2025	Dec 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023
Revenue	DKK 262.0m	DKK 249.0m	DKK 244.1m	DKK 251.5m	DKK 208.1m	DKK 104.0m	DKK 199.8m	DKK 99.9m
Gross profit	DKK 167.7m	DKK 161.0m	DKK 235.0m	DKK 230.5m	DKK 188.0m	DKK 94.0m	DKK 179.6m	DKK 89.8m
Operating income	DKK 130.4m	DKK 120.6m	DKK 112.5m	DKK 135.2m	DKK 89.0m	DKK 44.5m	DKK 89.8m	DKK 42.3m
Net income	DKK 107.9m	DKK 94.0m	DKK 83.1m	DKK 103.4m	DKK 65.7m	DKK 32.9m	DKK 70.6m	DKK 35.3m
Diluted earnings per share	6.20	5.40	4.77	5.94	3.78	1.89	4.05	2.03
Cash from operations	DKK 119.0m	DKK 90.0m	DKK 119.0m	DKK 88.0m	DKK 88.0m	DKK 44.0m	DKK 40.0m	DKK 20.0m
Capital spending	−DKK 16.0m	−DKK 11.0m	−DKK 19.0m	−DKK 10.0m	−DKK 13.0m	−DKK 6.0m	−DKK 7.0m	−DKK 3.0m
Free cash flow	DKK 103.0m	DKK 79.0m	DKK 100.0m	DKK 78.0m	DKK 75.0m	DKK 38.0m	DKK 33.0m	DKK 17.0m
Total assets	DKK 860.9m	DKK 783.4m	DKK 828.0m	DKK 730.2m	DKK 676.7m	DKK 676.7m	DKK 593.5m	DKK 593.5m
Cash and short-term investments	DKK 293.6m	DKK 274.7m	DKK 341.8m	DKK 264.7m	DKK 296.1m	DKK 296.1m	DKK 232.2m	DKK 232.2m
Debt	DKK 2.5m	DKK 2.4m	DKK 3.4m	DKK 3.1m	DKK 3.2m	DKK 3.2m	DKK 3.3m	DKK 3.3m
Shareholders' equity	DKK 725.4m	DKK 652.6m	DKK 673.4m	DKK 598.0m	DKK 565.3m	DKK 565.3m	DKK 498.7m	DKK 498.7m

Financial ratios

Data as of 11 Oct 2026

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021
Gross margin	95.1%	93.9%	90.1%	89.0%	89.7%	90.1%
Operating margin	49.1%	47.7%	43.3%	52.1%	47.8%	40.4%
Net margin	39.5%	37.6%	33.4%	40.2%	37.2%	31.4%
Return on equity	27.8%	27.7%	24.1%	33.5%	44.6%	33.3%
Return on assets	23.4%	22.5%	20.1%	27.2%	31.8%	25.6%
Free cash flow yield	2.3%	2.3%	1.7%	1.9%	2.3%	1.3%
Revenue growth	3.1%	21.5%	-8.2%	3.7%	52.4%	31.3%
Earnings growth	8.3%	36.8%	-23.7%	12.0%	80.5%	49.3%
Current ratio	4.09x	3.70x	4.97x	4.13x	2.57x	3.40x
Debt to equity	0.00x	0.01x	0.01x	0.01x	0.01x	0.01x
Equity ratio	84.3%	81.3%	83.5%	81.0%	71.3%	76.8%
Interest coverage	640.29x	379.03x	965.93x	212.73x	134.96x	123.80x
R&D as a share of sales	3.0%	2.1%	2.1%	1.6%	1.7%	2.3%
Buybacks as a share of market value	0.0%	-0.0%	0.1%	-0.1%	0.0%	0.0%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	4.8%	12.7%	19.6%
Operating income	3.2%	16.7%	31.8%
Net income	4.1%	18.0%	34.4%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	94.5%	92.2%	91.6%	91.1%
Operating margin	49.5%	48.7%	47.8%	43.4%
Net margin	38.6%	37.8%	37.0%	33.5%

Valuation history

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Price to earnings	55.6	38.1	36.9	22.5	44.8	97.5	101.0	47.6	42.9	32.6
Price to sales	21.9	14.3	12.3	9.0	16.7	30.6	27.9	11.3	6.9	2.7

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 10 Oct 2025.

	FY2026	FY2025	FY2024	FY2022	FY2021	FY2020
Paid in the year	7.00	4.00	6.00	4.00	1.50	20.50

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Chemometec A/S CHEMM.CO · DKK

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology